Related Experiment Video
Updated: Aug 11, 2025

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq
Published on: April 19, 2013
Irisin expression and FNDC5 (rs3480) gene polymorphism in type 2 diabetic patients with and without CAD
Amera Morad Foad1, Alshimaa Hafez1, Wael Youssef2
1Department of Medical Biochemistry, Faculty of Medicine, Sohag University, Sohag, Egypt.
Background:
Irisin was found to correlate with coronary artery disease (CAD) in diabetic patients. This study investigated the association of irisin and FNDC5 (SNP rs3480) with the presence and severity of CAD in T2DM.
Methods:
This cross-sectional study included 100 patients with T2DM divided into two groups, DM group (n = 50), including patients without CAD and CAD group (n = 50), including those confirmed to have CAD by coronary angiography. Irisin was measured. SNP rs3480 genotyping of FNDC5 was done.
Results:
Irisin levels were significantly lower in the CAD group (p < 0.001). The CAD group had significantly higher HbA1c and lower HDL (p < 0.001). Patients with controlled DM had significantly higher irisin levels (p < 0.001). single nucleotide polymorphism (SNP) rs3480 was not associated with irisin levels, and the FNDC5 rs3480 AA reference allele was significantly associated with significant CAD.
Conclusion:
Irisin appears to be protective against developing CAD in diabetic patients. Irisin level was an independent predictor of significant CAD in diabetic patients combined with the FNDC5 rs3480 genotype.
Clinical Trial Registration Number:
NCT04957823.
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Diabetes Mellitus: Type 2 and Gestational
Single Nucleotide Polymorphisms-SNPs

